​

Genenta Science S.p.A. Stock (NASDAQ:GNTA)


OwnershipChart

Previous Close

$0.63

52W Range

$0.55 - $4.06

50D Avg

$0.85

200D Avg

$1.06

Market Cap

$11.50M

Avg Vol (3M)

$53.93K

Beta

0.76

Div Yield

-

GNTA Company Profile


Genenta Science S.p.A. operates as a strategic consolidator that focuses on acquiring ownership of privately held companies operating in Italian national-security-regulated sectors. Its activities and acquisition strategy covers aerospace, defense, national security, and biotechnology/biosecurity. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.

Show More

Industry

Aerospace & Defense

Sector

Industrials

Exchange

NASDAQ

ADR

Yes

Country

IT

Employees

9

IPO Date

Dec 15, 2021

Website

GNTA Performance


Peer Comparison


TickerCompany
TELOTelomir Pharmaceuticals, Inc. Common Stock
MDCXMedicus Pharma Ltd. Common Stock
JUNSJupiter Neurosciences, Inc.
IPSCCentury Therapeutics, Inc.
INMBINmune Bio, Inc.
SKYESkye Bioscience, Inc.
MRSNMersana Therapeutics, Inc.